Search results
Private equity firms struggle to sell investments
Axios· 18 hours agoPrivate equity has a problem. By the numbers: Private equity firms are sitting on $3.2 trillion worth of unsold assets ...
Fintech firm Payactiv—valued at over $500 million in 2020—is seeking a minority investor
Fortune via AOL· 5 days agoIn January, DailyPay raised $175 million in debt and equity, snagging a $1.75 billion valuation on a...
Why Fidelis Insurance Holdings Plunged This Week
Motley Fool via Yahoo Finance· 2 days agoTherefore, this week's decline could be an opportunity. Private equity cashes out Fidelis is sort of an upstart insurance company, having just gone...
Private equity offer for MariaDB gets shareholder thumbsup
The Register· 5 days agoMariaDB shareholders have backed a private equity takeover offer for the troubled database vendor....
The IPO Dilemma: Encouraging Startups To List In London
Forbes· 2 days agoIf all goes according to plan, British educational computer maker, Raspberry Pi will shortly list on...
Reddit's upcoming IPO could reward its power users
TechCrunch· 2 days agoTechCrunch also has a great show on crypto, a show that interviews founders and more! Hello, and welcome back to Equity, the TechCrunch podcast where we unpack the numbers ...
Milwaukee-area manufacturer completes go-private transaction - Milwaukee Business Journal
The Business Journals· 4 days agoCore Industrial Partners, a Chicago private equity firm, announced Tuesday completing its take-...
Softbank-backed Oyo withdraws IPO papers for second time
Reuters· 4 days agoIndian budget hotel aggregator Oyo has withdrawn its papers for an initial public offering (IPO),...
Your guide to WeWork's CEO shuffle
TechCrunch· 6 hours agoHello and welcome back to Equity, TechCrunch’s venture capital-focused podcast, where we unpack the numbers behind the headlines.
Tempus, Chicago's biotech darling, files to go public
Crain s Chicago Business· 5 days agoThe company, founded in 2015, started out by providing genomic-sequencing services to treat cancers but has since expanded to other conditions. After several rounds of investment from venture-capital ...
